Llwytho...
Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth
INTRODUCTION: Recent years have seen a dramatic escalation of off-label prescribing for gabapentin and pregabalin (gabapentinoids) owing in part to generic versions of each being released over the past two decades, but also in part as a response to increasing calls for multimodal and non-opioid pain...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Pain Ther |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Springer Healthcare
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7648827/ https://ncbi.nlm.nih.gov/pubmed/32737803 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40122-020-00189-x |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|